Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington's disease mice - Wikidata - wikimedia - TriplyDB

Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington's disease mice

Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington's disease mice

http://www.wikidata.org/entity/Q35152150

about

Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation Products Mouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II.Mitochondrial lipids in neurodegeneration Identification of hepta-histidine as a candidate drug for Huntington's disease by in silico-in vitro- in vivo-integrated screens of chemical libraries The aggregation and inheritance of damaged proteins determines cell fate during mitosis.Autophagy and mitochondrial alterations in human retinal pigment epithelial cells induced by ethanol: implications of 4-hydroxy-nonenal.Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models Phospholipase A2 - nexus of aging, oxidative stress, neuronal excitability, and functional decline of the aging nervous system? Insights from a snail model system of neuronal aging and age-associated memory impairment Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives Interaction of aldehydes derived from lipid peroxidation and membrane proteins Potential biomarkers to follow the progression and treatment response of Huntington's disease.4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies Antioxidants in Huntington's disease.Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain.Paradoxical cellular effects and biological role of the multifaceted compound nordihydroguaiaretic acid.Huntington's Disease: Pathogenic Mechanisms and Therapeutic Targets.Neurite transection produces cytosolic oxidation, which enhances plasmalemmal repair.Larrea tridentata: A novel source for anti-parasitic agents active against Entamoeba histolytica, Giardia lamblia and Naegleria fowleri.Effect of Quercetin in the 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-Induced Mouse Model of Parkinson's Disease.Mitochondrial modulators improve lipid composition and attenuate memory deficits in experimental model of Huntington's disease.Rotenone Induces the Formation of 4-Hydroxynonenal Aggresomes. Role of ROS-Mediated Tubulin Hyperacetylation and Autophagic Flux Disruption.Postnatal melatonin treatment protects against affective disorders induced by early-life immune stimulation by reducing the microglia cell activation and oxidative stress.Remodeling of heterochromatin structure slows neuropathological progression and prolongs survival in an animal model of Huntington's disease.

P2860

Q26767051-BC6C9F97-F621-45B5-8172-BE2B9666FCC9 Q27005950-BB4DF9D5-9A7D-4D1D-84D0-A7E241E8575C Q28397548-CFAE32F1-C23D-4530-8D09-302905F6B332 Q28829351-249EF72A-9F49-4EE9-8E7D-D20F6446F9D2 Q33578623-7E8B3C59-9334-451D-967C-C6805813F7D4 Q34007755-D7CC1A7A-7237-4712-AF69-B77B674B0A91 Q34408158-9877BB11-CE31-4357-A304-A5D8CF308FE5 Q34630947-09BD3D02-EE21-4AC8-97CE-54FD14482120 Q35608958-164D5B6F-B0C1-47A6-9CB4-17A267F404C6 Q37142547-C6616F97-DDF1-43C5-A432-773F5D67CDAE Q37415254-58E3F005-C13A-4264-ACFA-0C082BCDCE4A Q37960537-839F774B-25EF-42E4-9E9E-DDB60F71953E Q37964359-22E4AAED-448A-4A63-BB40-F102F6A1E207 Q38050263-4D96F2DF-F9D7-4721-8883-13662B3A2D4F Q38237620-2D9316E6-EB77-4F1A-8EA5-2B824497FD70 Q38663090-B52BD1A9-8D9C-4D93-A72D-2A97075B7CB8 Q39365392-4E93AD8A-AD3E-4DC5-A06B-7ED59F1629D2 Q40100127-E92E9563-BE5A-47C5-BB43-69A724A63EAC Q42227324-782EAF84-4B76-4387-B303-D54410152FD4 Q45290056-A6ED40A0-0BF2-463F-B12F-D9AF6752CEB2 Q45291266-1090BDCB-955E-4B0D-9080-024AD93CF4DD Q46193080-551A9322-FBA4-4DD4-870C-15475FDE0196 Q48771662-6A2E1BFC-9DF4-4EA1-8B14-7826663A670B

P2860

Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington's disease mice

http://www.wikidata.org/entity/Q35152150

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Modulation of lipid peroxidati ...... y in Huntington's disease mice

@ast

Modulation of lipid peroxidati ...... y in Huntington's disease mice

@en

type

label

Modulation of lipid peroxidati ...... y in Huntington's disease mice

@ast

Modulation of lipid peroxidati ...... y in Huntington's disease mice

@en

prefLabel

Modulation of lipid peroxidati ...... y in Huntington's disease mice

@ast

Modulation of lipid peroxidati ...... y in Huntington's disease mice

@en

P1433

Q35152150-10F43CF2-1634-4D04-92F3-9AF5DEC78FE8

P1476

Q35152150-33CBA007-D158-49B5-8C23-BA6E19D0C423

P2093

Q35152150-0DE3CF1D-1DA5-487B-8CC5-02E2AF3B118B

Q35152150-273302DD-DF72-4A93-A719-C78830C10D07

Q35152150-7C88A376-320E-4DCA-B412-B9AB2B2E4678

Q35152150-8488EC3F-563B-4F49-9BA1-2605D0401FC7

Q35152150-9D0742F8-005C-4DA2-B1F1-BB86BE0B5612

Q35152150-AA780467-6D04-4FB4-9489-63C2A0AD5106

Q35152150-C68B3879-74E8-4694-9A62-5E250E0EC735

Q35152150-CB0E9F9E-6F73-4963-8CBE-9C64144078BB

P2860

Q35152150-003DB4E4-0FFC-4DF8-85DC-EE2DB032435E

Q35152150-02C5F00F-2D7F-47CB-BCAA-75FEAA69600C

Q35152150-03E797D9-B13B-44E7-B9E1-3188CC168182

Q35152150-0A9624AF-63B0-4D52-AFCC-19CB5D48A288

Q35152150-11C6DC54-9B87-456F-8D4F-DF34ECC43FF1

Q35152150-15DD88AA-43E3-4846-9731-0DBE54B74C7F

Q35152150-210CAD3D-7551-458D-BB0E-ECFB4D0088CD

Q35152150-2499227B-86DA-47C9-B993-877A3B1B0DEE

Q35152150-2564AE3A-AEFD-4ED9-B618-32D1C80C4B3B

Q35152150-2CA975BB-05E9-4D7E-A0FF-ECF9526D8280

P2888

Q35152150-5E2D76DD-4781-47A2-8D0E-569FADA76B83

P304

Q35152150-8C5050C9-1F94-4120-B85C-0E3717C1602F

P31

Q35152150-BCD08F8A-83DC-448A-BBFB-A6577FD86351

P356

Q35152150-2743B5F8-03C2-4468-BDD1-DF15266D243D

P433

Q35152150-AFCAD31A-FB5A-416F-8A17-79EC25D11136

P478

Q35152150-08B11F8A-27A0-487B-AD0B-9CA303922714

P577

Q35152150-EF984F0D-1FED-464E-B2FC-27472DB6A9BC

P5875

Q35152150-ED480675-D793-40CA-8648-F3E64E846216

P698

Q35152150-96E85655-F5E5-42EF-BD99-6EB8C9264E4C

P921

Q35152150-FF02A1CC-49F6-4291-AB7A-C9C619FD98E5

P932

Q35152150-F915EA0D-D9C3-4A48-80FF-7D62D70AC197

P356

S00401-010-0788-5

P1433

Acta Neuropathologica

P1476

Modulation of lipid peroxidati ...... y in Huntington's disease mice

@en

P2093

Ann McKee

http://www.w3.org/2001/XMLSchema#string

Bela Kosaras

http://www.w3.org/2001/XMLSchema#string

Hoon Ryu

http://www.w3.org/2001/XMLSchema#string

Junghee Lee

http://www.w3.org/2001/XMLSchema#string

Kerry Cormier

http://www.w3.org/2001/XMLSchema#string

Neil W Kowall

http://www.w3.org/2001/XMLSchema#string

Rajiv R Ratan

http://www.w3.org/2001/XMLSchema#string

Steve J Del Signore

http://www.w3.org/2001/XMLSchema#string

P2860

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

Unbiased gene expression analysis implicates the huntingtin polyglutamine tract in extra-mitochondrial energy metabolism

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease.

N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking.

The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation.

Huntington disease models and human neuropathology: similarities and differences

Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts.

Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease.

Larrea tridentata (Creosote bush), an abundant plant of Mexican and US-American deserts and its metabolite nordihydroguaiaretic acid.

P2888

s00401-010-0788-5

P304

487-498

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00401-010-0788-5

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49686274

http://www.w3.org/2001/XMLSchema#string

P698

21161248

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

3151672

http://www.w3.org/2001/XMLSchema#string